AFINITOR provides flexible dosing for individualized therapy1
- 10 mg daily is the recommended starting dose
- 2.5-mg and 5-mg tablets available if dose adjustment is required
- Office visits not required for administration, which may save time for patients and caregivers
- Take at a convenient time, the same time every day
- Once-daily oral administration
- Take consistently with or without food
aBC, advanced breast cancer; HR+, hormone receptor-positive.
1. AFINITOR [summary of product characteristics]. Novartis Pharma AG; 2017.